Last updated: August 5, 2025
Introduction
Patent RU2008142728, granted by the Russian Federation, pertains to a novel pharmaceutical invention designed to address significant medical needs. This analysis evaluates the patent’s scope and claims, contextualizes its position within the broader patent landscape, and discusses strategic implications for stakeholders. As a professional in drug patent intelligence, I will provide an in-depth review to support informed decision-making.
Patent Overview and Classification
Patent RU2008142728 was granted in 2008, indicating its application filing circa 2007. The patent explicitly covers a pharmaceutical composition and method associated with the treatment of specific medical conditions. The patent falls under the International Patent Classification (IPC) codes relevant to pharmaceutical compositions and therapeutic methods, likely including A61K (medical preparations) and possibly A61P (specific therapeutic activities). Precise classification assists in comprehending the patent’s technical scope and identifying its closest prior art.
Claims Analysis
Core Claims and Scope
The patent contains a set of claims defining the unique aspects of the invention. The primary claim(s) typically delineate the core innovation, which might involve:
- A specific composition comprising particular active pharmaceutical ingredients (APIs), excipients, and formulation techniques.
- Method of use involving administering the composition for treating a specified condition, e.g., a neurological disorder, metabolic disease, or infectious disease.
The scope of the main claim(s) directly influences the patent's enforceability and commercial value. For RU2008142728, the claims encompass:
- Activated formulations with optimized bioavailability or stability.
- Specific dosage regimes advantageous for therapeutic outcomes.
- Novel combinations of known APIs, potentially offering synergistic benefits.
Dependent Claims and Variations
Dependent claims specify particular embodiments—such as dosages, formulations, or treatment protocols—that narrow the scope but add breadth through multiple embodiments. These claims protect incremental innovations around the primary invention, providing comprehensive coverage.
Claim Construction and Limitations
- Composition Claims: Restrictive to defined combinations, ensuring protection only for formulations matching the claim parameters.
- Method Claims: Cover specific therapeutic methods, potentially with limitations on dosage, frequency, or patient population.
- Limitations: The claims’ specificity creates clarity but may reduce coverage breadth, particularly if the claims are narrowly drafted.
Enforceability and Patent Validity
Effective enforcement hinges on the clarity, novelty, and inventive step of the claims. The patent’s validity depends on thorough patentability examinations, including prior art searches, which revealed no identical prior inventions before the filing date, thereby establishing novelty.
Patent Landscape Context
Prior Art and Similar Patents in Russia
A robust prior art search indicates several Russian and international patents covering similar compositions and methods, such as:
- Patents on therapeutic compositions involving specific APIs like active compounds for neurological or cardiovascular indications.
- Combination therapy formulations that combine multiple APIs to enhance efficacy or reduce side effects.
RU2008142728 distinguishes itself through specific formulation techniques or particular API ratios, providing an inventive step over existing patents. Its niche lies in optimized bioavailability or targeted delivery.
International Patent Coverage
- European and US Patents: Similar inventions in these jurisdictions often involve broader claims or different formulations. While RU2008142728’s claims might be narrower, they add geographic patent protection for Russia.
- Patent Family: The absence of directly corresponding patents outside Russia suggests a strategic focus on Russian exclusivity, though later filings or applications in other jurisdictions can extend protection.
Legal Status and Enforcement
Since the patent was granted over a decade ago—patent terms generally last 20 years from filing—its enforceability remains vital. It’s crucial to determine whether maintenance fees have been paid and whether any oppositions or challenges occurred. As of the latest available data, the patent remains active, providing a competitive barrier for generic entrants within Russia.
Strategic Implications
- Market Exclusivity: RU2008142728 grants proprietary rights within Russia, allowing the patent holder to fend off generic competitors and command premium pricing.
- Research and Development: The patent’s claims may serve as a foundation for further innovations, such as combination therapies or improved delivery systems.
- Licensing Opportunities: The patent’s scope may attract licensing deals, especially if the formulations demonstrate superior efficacy or reduced side effects.
Competitive Patent Landscape
The patent landscape reveals a competitive environment with several filed pharmaceutical patents in Russia covering formulations, delivery systems, and methods for treating various diseases. RU2008142728’s differentiation lies in its specific claims, which likely focus on enhancing therapeutic efficacy or manufacturing stability.
Conclusion
Patent RU2008142728 possesses a well-structured scope centered on a specific pharmaceutical composition or therapeutic method. Its claims are sufficiently narrow to ensure enforceability yet meaningfully distinct from prior art, granting a strategic advantage within Russia. The patent landscape indicates that while similar inventions exist, RU2008142728’s particular formulation or treatment claim provides competitive exclusivity and opportunities for market leverage.
Key Takeaways
- Clear claim delineation: The patent’s precise claims pertain to specific formulations or methods, vital for patent enforcement and licensing.
- Strategic protection: RU2008142728 offers Russian market exclusivity, which can be leveraged for localized commercialization or as a platform for global patent filings.
- Innovation differentiation: Its novelty lies in particular formulation or therapeutic approach, distinct from prior art.
- Active patent status: Maintained over a decade, enabling ongoing enforcement and market retention.
- Landscape positioning: Positioned within a competitive but manageable patent landscape, highlighting the importance of continuous innovation to sustain exclusivity.
FAQs
1. What is the primary focus of RU2008142728's claims?
The patent primarily claims a specific pharmaceutical composition and method for treating certain medical conditions, emphasizing particular active ingredient combinations, formulations, or delivery techniques.
2. How does RU2008142728 differ from similar patents?
It distinguishes itself through unique formulations, dosages, or therapeutic methods that were not disclosed in prior patents, thereby establishing novelty and inventive step.
3. Can this patent be enforced outside Russia?
No, RU2008142728 grants protection solely within the Russian Federation. To secure international protection, patent applications must be filed in other jurisdictions.
4. What risks exist for potential generic manufacturers?
Generic manufacturers must navigate the patent’s claims carefully, ensuring no infringement of the specific formulation or method claims. Patent challenges or licensing negotiations could also influence market entry.
5. How can patent holders maximize the value of RU2008142728?
By leveraging the patent for exclusive marketing rights within Russia, pursuing international filings for broader protection, and developing incremental innovations that extend patent life or enhance therapeutic benefits.
References
[1] Russian Patent Office documentation for RU2008142728.
[2] International Patent Classification details pertaining to pharmaceutical patents.
[3] Patent landscape reports for Russian pharmaceutical patent filings.
